Production of an agonist-like monoclonal antibody to the human A2A receptor of adenosine for clinical use
Authors:
- Josée-Martine Durand-GordeJDJosée-Martine Durand-Gorde
- Jocelyne CondoJCJocelyne Condo
- Pierre-Jean LejeunePLPierre-Jean Lejeune
- Bernard MalletBMBernard Mallet
- Pierre CarayonPCPierre Carayon
- Régis GuieuRGRégis Guieu
- Jean RufJRJean Ruf
- 1 January 2009
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 46 (3) , 400-405
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Suppression of inflammatory and immune responses by the A2Aadenosine receptor: an introductionBritish Journal of Pharmacology, 2008
- Adenosine receptors and asthmaBritish Journal of Pharmacology, 2008
- Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cellsBritish Journal of Pharmacology, 2008
- Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncopeHeart Rhythm, 2007
- Influence of haemodialysis and left ventricular failure on peripheral A2A adenosine receptor expressionNephrology Dialysis Transplantation, 2007
- Changes of peripheral A 2A adenosine receptors in chronic heart failure and cardiac transplantationThe FASEB Journal, 2002
- A2A adenosine receptors in human peripheral blood cellsBritish Journal of Pharmacology, 2000
- Anti‐peptide antibodies sensitive to the ‘active’ state of the β2‐adrenergic receptorFEBS Letters, 1996
- Structural basis of autoimmunity against G protein coupled membrane receptorsInternational Journal of Cardiology, 1996
- Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopyJournal of Molecular Biology, 1990